Balaxi Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE618N01022
  • NSEID: BALAXI
  • BSEID:
INR
27.83
-0.28 (-1.0%)
BSENSE

Dec 19

BSE+NSE Vol: 88186

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
11.04
10.90
10.18
10.00
10.00
10.00
Share Warrants & Outstandings
Total Reserve
220.69
186.69
162.40
103.16
54.98
17.75
Shareholder's Funds
231.74
201.36
182.88
113.16
64.98
27.75
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.90
1.00
1.10
0.04
0.01
0.00
Other Long Term Liabilities
1.8
1.74
1.69
0
0
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.13
0.04
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
24.07
2.78
3.66
0.04
0.01
0.00
Current Liabilities
Trade Payables
16.18
29.04
34.52
49.11
24.88
5.73
Other Current Liabilities
7.97
7.50
7.86
10.52
6.15
0.07
Short Term Borrowings
30.38
17.66
10.75
3.64
3.66
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
2.42
Total Current Liabilities
54.53
54.20
53.13
63.27
34.69
8.22
Total Liabilities
310.34
258.34
239.67
176.47
99.68
35.97
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
42.88
42.98
43.00
29.23
2.74
0.19
Less: Accumulated Depreciation
1.89
2.10
1.60
0.47
0.30
0.00
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
40.98
40.88
41.41
28.76
2.45
0.19
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
22.07
2.31
2.83
0.57
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
3.42
0.00
Long Term Loans & Advances
4.03
4.58
1.52
5.74
0.05
0.92
Other Non Current Assets
0.50
0.40
0.40
0.40
0.00
0.00
Total Non-Current Assets
67.58
48.17
46.16
35.47
5.91
1.11
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
78.48
82.17
105.02
98.70
13.62
0.83
Sundry Debtors
110.80
55.71
52.28
27.56
76.76
29.71
Cash and Bank
39.40
62.29
28.22
7.19
1.67
4.00
Other Current Assets
3.52
2.30
4.02
4.40
0.05
0.00
Short Term Loans and Advances
10.57
7.71
3.96
3.15
1.67
0.31
Total Current Assets
242.77
210.17
193.51
141.00
93.77
34.86
Net Current Assets (Including Current Investments)
188.23
155.97
140.38
77.74
59.08
26.64
Total Current Assets Excluding Current Investments
242.77
210.17
193.51
141.00
93.77
34.86
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
310.34
258.34
239.67
176.47
99.68
35.97
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
51.62
17.66
11.62
3.64
3.66
0.00
Book Value per share (adjusted)
41.98
7.252
33.902
113.16
12.996
5.55
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 192.30% vs 51.98% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 3.45% vs 2.96% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 46.01% vs -2.37% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 15.51% vs 8.61% in Mar 2024

Compare Balance Sheet Results of Balaxi Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
11.04
0
11.04
0.00%
Share Warrants & Outstandings
Total Reserve
220.69
0
220.69
0.00%
Shareholder's Funds
231.74
0
231.74
0.00%
Minority Interest
0.00
0
0.00
0.00%
Long-Term Borrowings
0.00
0
0.00
0.00%
Secured Loans
0.00
0
0.00
0.00%
Unsecured Loans
0.00
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0.90
0
0.90
0.00%
Other Long Term Liabilities
1.80
0
1.80
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.13
0
0.13
0.00%
Total Non-Current Liabilities
24.07
0
24.07
0.00%
Current Liabilities
Trade Payables
16.18
0
16.18
0.00%
Other Current Liabilities
7.97
0
7.97
0.00%
Short Term Borrowings
30.38
0
30.38
0.00%
Short Term Provisions
0.00
0
0.00
0.00%
Total Current Liabilities
54.53
0
54.53
0.00%
Total Liabilities
310.34
0
310.34
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
42.88
0
42.88
0.00%
Less: Accumulated Depreciation
1.89
0
1.89
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
40.98
0
40.98
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
22.07
0
22.07
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.00
0
0.00
0.00%
Long Term Loans & Advances
4.03
0
4.03
0.00%
Other Non Current Assets
0.50
0
0.50
0.00%
Total Non-Current Assets
67.58
0
67.58
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
78.48
0
78.48
0.00%
Sundry Debtors
110.80
0
110.80
0.00%
Cash and Bank
39.40
0
39.40
0.00%
Other Current Assets
3.52
0
3.52
0.00%
Short Term Loans and Advances
10.57
0
10.57
0.00%
Total Current Assets
242.77
0
242.77
0.00%
Net Current Assets (Including Current Investments)
188.23
0
188.23
0.00%
Total Current Assets Excluding Current Investments
242.77
0
242.77
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
310.34
0
310.34
0.00%
Contingent Liabilities
0.00
0
0.00
0.00%
Total Debt
51.62
0
51.62
0.00%
Book Value per share (adjusted)
41.98
0
41.98
0.00%
Annual - Borrowings
Borrowings 51.62 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 192.30% vs 51.98% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 3.45% vs 2.96% in Mar 2024

Annual - Fixed Assets
Fixed Assets 63.06 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 46.01% vs -2.37% in Mar 2024

Annual - Investments
Investments 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 242.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.51% vs 8.61% in Mar 2024